These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4285237)

  • 21. Thymidine kinase activity of ocular herpes simplex isolates resistant to IUDR therapy.
    Funderburgh ML; Funderburgh JL; Chandler JW
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1546-8. PubMed ID: 3759371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report on 36 patients with dendritic corneal ulceration treated with IDU ('stoxil').
    SWARTZ J
    S Afr Med J; 1963 May; 37():552-3. PubMed ID: 13979649
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 24. TREATMENT OF HERPETIC KERATITIS WITH IDU AND CORTICOSTEROIDS; REPORT OF 105 CASES.
    THOMAS CI; PURNELL EW; ROSENTHAL MS
    Am J Ophthalmol; 1965 Aug; 60():204-17. PubMed ID: 14333974
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of virus from herpetic keratitis. Influence of idoxuridine on isolation rates.
    Coleman VR; Thygeson P; Dawson CR; Jawetz E
    Arch Ophthalmol; 1969 Jan; 81(1):22-4. PubMed ID: 4303160
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in thymidine kinase-inducing ability of herpesvirus types 1 and 2.
    Lowry SP; Bresnick E; Rawls WE
    Virology; 1971 Dec; 46(3):958-61. PubMed ID: 5002940
    [No Abstract]   [Full Text] [Related]  

  • 27. [Susceptibility of herpes simplex virus to IDU].
    Kobayashi S; Shoji K; Asayama T
    Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1201-5. PubMed ID: 4295684
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
    Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine.
    Kodama E; Mori S; Shigeta S
    Antiviral Res; 1995 May; 27(1-2):165-70. PubMed ID: 7486953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.
    Tenser RB; Jones JC; Ressel SJ
    J Infect Dis; 1985 Mar; 151(3):548-50. PubMed ID: 2982968
    [No Abstract]   [Full Text] [Related]  

  • 31. Trifluorthymidine in the treatment of herpes simplex corneal ulcers. A clinical evaluation.
    Gilbert P; Work K
    Acta Ophthalmol (Copenh); 1980; 58(1):117-20. PubMed ID: 6773292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs.
    Langlois M; Allard JP; Nugier F; Aymard M
    J Biol Stand; 1986 Jul; 14(3):201-11. PubMed ID: 3020058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical resistance of herpetic keratitis to antiviral agents (author's transl)].
    Colin J; Chastel C; Baikoff G; Renard G
    J Fr Ophtalmol; 1981; 4(1):57-60. PubMed ID: 6260850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [TOLERANCE AND ACTIVITY OF 5-IODO-2'-DEOXYURIDINE IN OPHTHALMOLOGY].
    BOUZAS A
    Ophthalmologica; 1964; 148():24-41. PubMed ID: 14185132
    [No Abstract]   [Full Text] [Related]  

  • 35. Herpes simplex virus types 1 and 2: therapeutic response to antiviral drugs.
    North RD; Pavan-Langston D; Geary P
    Arch Ophthalmol; 1976 Jun; 94(6):1019-21. PubMed ID: 180942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of resistance to antiviral drugs.
    Renis HE; Buthala DA
    Ann N Y Acad Sci; 1965 Jul; 130(1):343-54. PubMed ID: 4285582
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative aspects of thymidine uptake into the acid-souble pool of normal and polyoma-transformed hamster cells.
    Hare JD
    Cancer Res; 1970 Mar; 30(3):684-91. PubMed ID: 4316599
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy of experimental herpes simplex keratitis in rabbits with 5-lodo-5'-amino-2',5'-dideoxyuridine (39882).
    Puliafito CA; Robinson NL; Albert DM; Pavan-Langston D; Lin TS; Ward DC; Prusoff WH
    Proc Soc Exp Biol Med; 1977 Oct; 156(1):92-6. PubMed ID: 198822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.